Research & Development

久草在线资源站俺去也电影网anquye-俺去了深交所对暴风发关注函 是否涉嫌单位犯罪?


  曹襄並不生氣,他知道霍去病這是有些嫉妒他,天生的富貴命,別人不服不行。   太陽出來的時候,濃霧就散去了,只有驪山上還有一層薄薄的水霧,不過,也很快就消失在林莽中了。久草在线资源站   他很想把火藥塞進竹管里面點燃……其實他已經這樣做了……只是被師傅揍了一頓之後沒收了竹管。俺去也电影网   雲瑯幽怨的瞅著進門的霍去病道︰“小光不會用火藥去炸你母親的。”   張騫拱手道︰“大致不差!”anquye-俺去了   這就是要從漩渦中心避開啊。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo